Wednesday, April 24, 2024
HomeRecent ArticlesSingapore-based Mesh Bio Secures US$3.5 Mn Series A Funding

Singapore-based Mesh Bio Secures US$3.5 Mn Series A Funding

Multidimensional Health Intelligence Platform for digital powered care delivery, Mesh Bio has Secured US$3.5 Million Series A Funding led by East Ventures and other investors included in Elev8, Seed Capitals, and other existing shareholders.

Multidimensional Health Intelligence Platform for digital powered care delivery, Mesh Bio has Secured US$3.5 Million Series A Funding led by East Ventures and other investors included in Elev8, Seed Capitals, and other existing shareholders.

Read also – Roboost Secures USD3 Mn Funding

With this investment, Mesh Bio will be able to expand the implementation of its digital twin technologies throughout Southeast Asia, namely Indonesia and the Philippines, as well as Hong Kong, by providing them to healthcare professionals.

Read also – Saudi Arabia-based Ejaro Secures USD 3.3Mn Pre-Series A Funding

“We are excited to announce the closure of our Series A funding, this pivotal step empowers us to expand our digital health solutions for chronic disease management in Southeast Asia,” said Dr. Andrew Wu, Co-Founder and Chief Executive Officer of Mesh Bio.“Southeast Asia presents myriad unmet healthcare needs, and our focus is to address these gaps effectively, “With East Ventures’ support, we are poised to support the rapid digital transformation of healthcare systems in this region to improve lives. We deeply appreciate their belief in our mission and commitment to healthcare innovation”.

Read also – XREAL Announces USD $60M in Strategic Funding Round

“Their innovative approach to harnessing predictive analytics is a game-changer, enabling more personalized and preventive healthcare services. We look forward to further collaboration in transforming healthcare systems in Southeast Asia and beyond,” said Willson Cuaca, Co-Founder and Managing Partner at East Ventures.

Read also – Yspot Announces Partnership between Virtuzone and GEMS Education

About Mesh Bio

Founded in 2018, Multidimensional Health Intelligence Platform for digital powered care delivery. Mesh Bio is a fast growing digital health startup focused on addressing the growing challenges in care delivery. Mesh Bio develops AI powered clinical decision support, analytics and automation solutions for healthcare providers to transform healthcare delivery with digital solutions.

Read also – BluSmart Secures $25 Mn Funding From ResponsAbility

- Advertisement -
RELATED ARTICLES
- Advertisment -

Most Popular